Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ying Xing
Baoding People's Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
58
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Empagliflozin for the Treatment of Liver Cirrhosis with Refractory Ascites: A Pilot-Controlled Study
Number of pages: 31
Posted: 21 Nov 2024
Rongya Shi
,
Yunyi Gao
,
Wei Qin
,
Yixi Dong
,
Longzhen Zhou
,
Congxing Qi
, Ying Xing,
Chaonan Wang
,
Shilei Huang
,
Yuanyuan Zhao
,
Jiaojiao Song
,
Wenhong Wang
,
Liwei Liu
,
Menghua Wu
,
Hanlu You
,
Jianru Jia
,
Yuan Gao
and
Zhongjie Hu
Baoding People's Hospital, Beijing Red Cross Blood Center, Baoding People's Hospital, University of Science and Technology of China (USTC), Chinese Academy of Sciences (CAS), Baoding People's Hospital, Baoding People's Hospital, Baoding People's Hospital, Baoding People's Hospital, Baoding People's Hospital, Baoding People's Hospital, Baoding People's Hospital, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University, Capital Medical University and Capital Medical University
Downloads
58
(786,223)
View PDF
Download
Abstract:
cirrhosis, ascites, sodium-glucose linked transporter 2 inhibitors, empagliflozin.
Feedback